NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 5 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Sukhodolsky, Denis G.; Lecavalier, Luc; Johnson, Cynthia; Smith, Tristram; Swiezy, Naomi; Bearss, Karen; Kalvin, Carla B.; Scahill, Lawrence – Autism: The International Journal of Research and Practice, 2020
Anxiety is a common and impairing problem in children with autism spectrum disorder, but little is known about it in preschool children with autism spectrum disorder. This article reports on the characteristics of anxiety symptoms in young children with autism spectrum disorder using a parent-completed rating scale. One hundred and eighty children…
Descriptors: Anxiety, Young Children, Autism, Pervasive Developmental Disorders
Peer reviewed Peer reviewed
Direct linkDirect link
Erickson, Craig A.; Veenstra-Vanderweele, Jeremy M.; Melmed, Raun D.; McCracken, James T.; Ginsberg, Lawrence D.; Sikich, Linmarie; Scahill, Lawrence; Cherubini, Maryann; Zarevics, Peter; Walton-Bowen, Karen; Carpenter, Randall L.; Bear, Mark F.; Wang, Paul P.; King, Bryan H. – Journal of Autism and Developmental Disorders, 2014
STX209 (arbaclofen), a selective GABA-B agonist, is hypothesized to modulate the balance of excitatory to inhibitory neurotransmission, and has shown preliminary evidence of benefit in fragile X syndrome. We evaluated its safety, tolerability, and efficacy in non-syndromic autism spectrum disorders, in an 8-week open-label trial enrolling 32…
Descriptors: Autism, Pervasive Developmental Disorders, Symptoms (Individual Disorders), Drug Therapy
Peer reviewed Peer reviewed
Direct linkDirect link
Scahill, Lawrence; Hallett, Victoria; Aman, Michael G.; McDougle, Christopher J.; Arnold, L. Eugene; McCracken, James T.; Tierney, Elaine; Deng, Yanhong; Dziura, James; Vitiello, Benedetto – Journal of Autism and Developmental Disorders, 2013
There is growing interest in measuring social disability as a core element of autism spectrum disorders in medication trials. We conducted a secondary analysis on the Aberrant Behavior Checklist Social Withdrawal subscale using data from two federally-funded, multi-site, randomized trials with risperidone. Study 1 included 52 subjects assigned to…
Descriptors: Autism, Pharmacology, Effect Size, Pervasive Developmental Disorders
Peer reviewed Peer reviewed
Direct linkDirect link
Capone, George T.; Aidikoff, Jenna M.; Goyal, Parag – Journal of Mental Health Research in Intellectual Disabilities, 2011
Caretakers of adolescents and young adults with Down syndrome (DS) may report the onset of a depressive illness in previously mentally well individuals. However, the behavioral phenomenology of these conditions has not been well characterized. We ascertained a cohort of DS patient-subjects presenting to a specialty clinic with medical and/or…
Descriptors: Anxiety, Attention Span, Autism, Withdrawal (Psychology)
Peer reviewed Peer reviewed
Direct linkDirect link
Carminati, Giuliana Galli; Gerber, Fabienne; Baud, Marc Andre; Baud, Olivier – Research in Autism Spectrum Disorders, 2007
This study observes the evolution of persons with pervasive developmental disorders (PDD) and profound intellectual disabilities living in residences with a Program for Residents with Autism Spectrum Disorders (ASD) characterised by a different educator's presence ratio and different logistic accommodations. This population is characterised by the…
Descriptors: Autism, Program Effectiveness, Adults, Pervasive Developmental Disorders